NZ208013A - Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora - Google Patents
Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucososporaInfo
- Publication number
- NZ208013A NZ208013A NZ208013A NZ20801384A NZ208013A NZ 208013 A NZ208013 A NZ 208013A NZ 208013 A NZ208013 A NZ 208013A NZ 20801384 A NZ20801384 A NZ 20801384A NZ 208013 A NZ208013 A NZ 208013A
- Authority
- NZ
- New Zealand
- Prior art keywords
- bbm
- exhibits
- methanol
- strain
- silica gel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49523183A | 1983-05-16 | 1983-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ208013A true NZ208013A (en) | 1987-07-31 |
Family
ID=23967812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ208013A NZ208013A (en) | 1983-05-16 | 1984-05-01 | Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora |
Country Status (28)
Country | Link |
---|---|
JP (2) | JPS59232094A (pt) |
KR (2) | KR840008817A (pt) |
AT (1) | AT393691B (pt) |
AU (1) | AU569294B2 (pt) |
BE (1) | BE899667A (pt) |
CA (1) | CA1241282A (pt) |
CY (1) | CY1465A (pt) |
DE (1) | DE3418023A1 (pt) |
DK (1) | DK163127C (pt) |
ES (1) | ES8700267A1 (pt) |
FI (1) | FI81114C (pt) |
FR (1) | FR2547594B1 (pt) |
GB (1) | GB2141425B (pt) |
GR (1) | GR81581B (pt) |
HK (1) | HK9889A (pt) |
HU (1) | HU193928B (pt) |
IE (1) | IE57444B1 (pt) |
IL (1) | IL71824A (pt) |
IT (1) | IT1175498B (pt) |
KE (1) | KE3846A (pt) |
LU (1) | LU85362A1 (pt) |
NL (1) | NL8401572A (pt) |
NZ (1) | NZ208013A (pt) |
PT (1) | PT78590A (pt) |
SE (1) | SE460364B (pt) |
SU (1) | SU1344249A3 (pt) |
YU (1) | YU43846B (pt) |
ZA (1) | ZA843591B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR78648B (pt) * | 1982-07-26 | 1984-09-27 | Bristol Myers Co | |
IL79519A0 (en) * | 1985-08-27 | 1986-10-31 | Bristol Myers Co | Bbm-1675c and d antitumor antibiotics |
US4837206A (en) * | 1987-04-29 | 1989-06-06 | Bristol-Myers Company | Esperamicin derivatives |
US4996305A (en) * | 1988-02-29 | 1991-02-26 | American Cyanamid Company | Process for producing the antibiotic and antitumor agents LL-E33288.epsilon.ε-Br |
CA2027601A1 (en) * | 1989-11-06 | 1991-05-07 | Koko Sugawara | Antitumor antibiotic bu-3983t |
WO2022196275A1 (ja) * | 2021-03-17 | 2022-09-22 | 日本水産株式会社 | 精製の方法および精製された製品 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4195079A (en) * | 1979-01-31 | 1980-03-25 | Pfizer Inc. | New polycyclic ether antibiotic |
JPS56113791A (en) * | 1980-02-15 | 1981-09-07 | Kaken Pharmaceut Co Ltd | Novel antibiotic and its preparation |
GR78648B (pt) * | 1982-07-26 | 1984-09-27 | Bristol Myers Co | |
US4539203A (en) * | 1984-11-13 | 1985-09-03 | Warner-Lambert Company | CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use |
-
1984
- 1984-05-01 NZ NZ208013A patent/NZ208013A/en unknown
- 1984-05-08 GR GR74646A patent/GR81581B/el unknown
- 1984-05-08 AU AU27791/84A patent/AU569294B2/en not_active Ceased
- 1984-05-08 CA CA000453762A patent/CA1241282A/en not_active Expired
- 1984-05-11 ZA ZA843591A patent/ZA843591B/xx unknown
- 1984-05-11 FI FI841906A patent/FI81114C/fi not_active IP Right Cessation
- 1984-05-14 ES ES532476A patent/ES8700267A1/es not_active Expired
- 1984-05-14 IL IL71824A patent/IL71824A/xx unknown
- 1984-05-15 DE DE19843418023 patent/DE3418023A1/de active Granted
- 1984-05-15 IE IE1200/84A patent/IE57444B1/en not_active IP Right Cessation
- 1984-05-15 BE BE0/212942A patent/BE899667A/fr not_active IP Right Cessation
- 1984-05-15 SU SU843744582A patent/SU1344249A3/ru active
- 1984-05-15 FR FR8407477A patent/FR2547594B1/fr not_active Expired
- 1984-05-15 LU LU85362A patent/LU85362A1/fr unknown
- 1984-05-15 HU HU841877A patent/HU193928B/hu not_active IP Right Cessation
- 1984-05-15 IT IT20928/84A patent/IT1175498B/it active
- 1984-05-15 GB GB08412368A patent/GB2141425B/en not_active Expired
- 1984-05-15 SE SE8402619A patent/SE460364B/sv not_active IP Right Cessation
- 1984-05-15 DK DK239784A patent/DK163127C/da not_active IP Right Cessation
- 1984-05-16 PT PT78590A patent/PT78590A/pt not_active IP Right Cessation
- 1984-05-16 AT AT0160984A patent/AT393691B/de not_active IP Right Cessation
- 1984-05-16 NL NL8401572A patent/NL8401572A/nl not_active Application Discontinuation
- 1984-05-16 YU YU849/84A patent/YU43846B/xx unknown
- 1984-05-16 JP JP59096758A patent/JPS59232094A/ja active Granted
- 1984-05-16 KR KR1019840002636A patent/KR840008817A/ko not_active Application Discontinuation
-
1988
- 1988-11-21 KE KE3846A patent/KE3846A/xx unknown
-
1989
- 1989-02-02 HK HK98/89A patent/HK9889A/xx unknown
- 1989-05-04 KR KR1019890006047A patent/KR920001366B1/ko not_active IP Right Cessation
- 1989-07-21 CY CY1465A patent/CY1465A/xx unknown
- 1989-08-24 JP JP1216009A patent/JPH02128693A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4675187A (en) | BBM-1675, a new antibiotic complex | |
US4518589A (en) | BBM-2478 Antibiotic complex | |
EP0095154A1 (en) | Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions | |
GB2164035A (en) | A novel antibiotic and production thereof | |
US4567143A (en) | Process for preparing 4'-deschlororebeccamycin | |
US4582639A (en) | Antitumor antibiotic compound | |
NZ208013A (en) | Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora | |
CA1093998A (en) | Antitumor antibiotic baumycin complex and components thereof | |
AU633826B2 (en) | Bu-3420t antitumor antibiotic | |
US4792522A (en) | Rigolettone antitumor complex | |
US4598145A (en) | Albacarcins V and M | |
CA1210350A (en) | Antibiotic complex producing bacterial culture | |
US4708872A (en) | Antitumor antibiotic complex | |
US4626503A (en) | Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3 | |
US4599310A (en) | Process for producing antitumor antibiotic compound | |
US4868117A (en) | BBM-1675, a new antitumor antibiotic complex | |
US4301248A (en) | Fermentation process for making rachelmycin | |
US4461831A (en) | Antitumor agents albacarcins V and M | |
US4572895A (en) | Process for preparing an antibiotic complex by culturing actinomyces strain ATCC 39417 | |
US4686308A (en) | Novel physiologically active substance MH435 | |
US5021549A (en) | Physiologically active substances, probestin and prostatin and production thereof | |
EP0157203A2 (en) | Antitumor agents LL-D49194 alpha 1, LL-D49194 beta, LL-D49194 beta 2, LL-D49194 upsilon, LL-D49194 delta, LL-D49194 epsilon, LL-D49194 zeta, and LL-D49194 eta | |
US4956374A (en) | Polysubstituted thiazolylpyridine carboxyamide antifungal antibiotic | |
CA2164618A1 (en) | Compound ge3 | |
CH663155A5 (en) | Antitumour antibiotics |